Growth Metrics

Rapid Micro Biosystems (RPID) Gains from Investment Securities (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Gains from Investment Securities for 6 consecutive years, with -$550000.0 as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 466.67% to -$550000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$131000.0 through Dec 2025, down 187.33% year-over-year, with the annual reading at -$131000.0 for FY2025, 187.33% down from the prior year.
  • Gains from Investment Securities hit -$550000.0 in Q4 2025 for Rapid Micro Biosystems, down from $1000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $7.6 million in Q4 2022 to a low of -$19.6 million in Q4 2021.
  • Historically, Gains from Investment Securities has averaged -$255481.2 across 5 years, with a median of $1000.0 in 2024.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 3674.68% in 2021 and later skyrocketed 6000.0% in 2025.
  • Year by year, Gains from Investment Securities stood at -$19.6 million in 2021, then skyrocketed by 138.63% to $7.6 million in 2022, then plummeted by 100.11% to -$8000.0 in 2023, then surged by 1975.0% to $150000.0 in 2024, then tumbled by 466.67% to -$550000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for RPID at -$550000.0 in Q4 2025, $1000.0 in Q3 2025, and $427000.0 in Q2 2025.